Finally, data obtained from Fst gene therapy studies in both human and nonhuman primates did not indicate apparent structural or functional aberration in various tissues, suggesting that FST may have therapeutic potential in clinical settings for the treatment of obesity and related diseases. The gene discussed is FST; the disease is Obesity.